Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A
2006 · Blood · 218 citations
https://doi.org/10.1182/blood-2006-05-024711
K
Kaan Kavaklı
Ege University(TR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
163
Papers
3.0K
Citations
28
h-index
61
i10-index
Kaan Kavaklı is an academic researcher from Ege University. The author has contributed to research in topics: Hemophilia Treatment and Research & Blood Coagulation and Thrombosis Mechanisms & Platelet Disorders and Treatments. The author has an h-index of 28, co-authored 139 publications.
ORCID: 0000-0002-4910-2142Papers by this author
worksGene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B
2024 · New England Journal of Medicine · 66 citations
https://doi.org/10.1056/nejmoa2302982
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity
2015 · Journal of Thrombosis and Haemostasis · 59 citations
https://doi.org/10.1111/jth.13141
Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency
2021 · Blood Reviews · 31 citations
https://doi.org/10.1016/j.blre.2021.100833
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
2019 · Research and Practice in Thrombosis and Haemostasis · 19 citations
https://doi.org/10.1002/rth2.12204
Turoctocog alfa pegol (N8‐GP) in severe hemophilia A: Long‐term safety and efficacy in previously treated patients of all ages in the pathfinder8 study
2022 · Research and Practice in Thrombosis and Haemostasis · 10 citations
https://doi.org/10.1002/rth2.12674
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat